Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders

Scientists have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.

from Latest Science News -- ScienceDaily https://ift.tt/vbSfPCx

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence